PDUFA VI: FDA Wary Of Industry Proposals With More Metrics
This article was originally published in The Pink Sheet Daily
Executive Summary
Review system proposals could overburden staff, FDA says; formal meeting goals already on tap for changes.
You may also be interested in...
Breakthrough Requests: FDA Adds Quick Screen To Pare Workload
Hope is to quickly reject obviously inadequate designation requests, but few meet criteria for dismissal so far.
PDUFA Negotiations Begin With FDA Seeking Review System Reform
Fee structure changes and process enhancements floated during opening session between industry and agency.
Does PDUFA Need A Haircut? FDA Ponders Trimming Its Responsibilities
Acting Commissioner Ostroff wonders if all aspects of user fee program are delivering maximum added value.